| Argo Investments Limited (ARG) ORDINARY FULLY PAID |
Financials |
$6,556 |
Weekly NTA estimate - Fri 20.6.25
|
23 Jun 2025 1:14PM |
$8.950 |
$8.640 |
fallen by
3.46%
|
|
| Aurizon Holdings Limited (AZJ) ORDINARY FULLY PAID |
Industrials |
$7,036 |
Becoming a substantial holder
|
23 Jun 2025 1:03PM |
$3.025 |
$4.180 |
risen by
38.18%
|
|
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$405 |
Notification of cessation of securities - RG8
|
23 Jun 2025 12:56PM |
$1.900 |
$2.810 |
risen by
47.89%
|
|
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
- |
Notification of cessation of securities - VG1
|
23 Jun 2025 12:53PM |
$1.660 |
$1.950 |
risen by
17.47%
|
|
| Aruma Resources Limited (AAJ) ORDINARY FULLY PAID |
Materials |
$11 |
Notification regarding unquoted securities - AAJ
|
23 Jun 2025 12:40PM |
$0.010 |
$0.015 |
risen by
57.89%
|
|
| Clime Investment Management Ltd (CIW) ORDINARY FULLY PAID |
Financials |
$26 |
Notification of cessation of securities - CIW
|
23 Jun 2025 12:39PM |
$0.370 |
$0.315 |
fallen by
14.86%
|
|
| MA Credit Income Trust (MA1) ORDINARY UNITS FULLY PAID |
- |
$552 |
Daily Estimate NTA for 20.06.2025
|
23 Jun 2025 12:36PM |
$2.020 |
$1.975 |
fallen by
2.23%
|
|
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$44 |
Reinstatement to Quotation
|
23 Jun 2025 12:35PM |
$0.115 |
$0.072 |
fallen by
37.39%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Microba Life Sciences Limited (MAP) announced reinstatement to quotation on the ASX effective 13 June 2024.
- Reinstatement follows the successful acquisition of Unit 820 Pty Ltd (Anatara Lifesciences).
- MAP has satisfied all ASX listing rules and provided an updated statement of commitments and capital structure.
- Shares will resume normal trading on the ASX.
- The company’s board and management have undergone changes following the acquisition.
- Corporate strategy is updated to emphasize microbiome-based diagnostics and therapeutics.
- Integration of Anatara’s assets is expected to enhance MAP’s product and technology pipeline.
- The announcement includes compliance disclosures, updated risk factors, and a timeline for implementation.
- MAP’s focus remains on advancing its proprietary gut microbiome testing and therapeutic development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$44 |
Proposed issue of securities - MAP
|
23 Jun 2025 12:35PM |
$0.115 |
$0.072 |
fallen by
37.39%
|
|
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$44 |
Proposed issue of securities - MAP
|
23 Jun 2025 12:35PM |
$0.115 |
$0.072 |
fallen by
37.39%
|
|
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$44 |
Proposed issue of securities - MAP
|
23 Jun 2025 12:35PM |
$0.115 |
$0.072 |
fallen by
37.39%
|
|
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$44 |
Strategic Investment & Equity Raise Presentation
|
23 Jun 2025 12:35PM |
$0.115 |
$0.072 |
fallen by
37.39%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Microba Life Sciences Limited announces a strategic investment and equity raise led by Ginkgo Bioworks.
- The investment aims to accelerate Microba’s drug discovery and development pipeline in IBD and immuno-oncology.
- The partnership gives Microba access to Ginkgo Bioworks’ advanced cell programming and data platform.
- A collaboration agreement is established for microbiome therapeutics development.
- Proceeds will support clinical programs, global pharma partnerships, and innovation in precision medicine.
- The equity raise was strongly supported by new and existing institutional and strategic investors.
- Microba’s proprietary MAP (Microbiome Analysis Platform) remains central to its strategy.
- The transaction is expected to enhance Microba’s leadership in the global microbiome sector.
- Funds will be used to progress clinical-stage assets, expand pharma collaborations, and reinforce the company’s research capabilities.
- Microba is positioned as a front-runner in precision microbiome-based drug development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$44 |
Proposed issue of securities - MAP
|
23 Jun 2025 12:35PM |
$0.115 |
$0.072 |
fallen by
37.39%
|
|
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$44 |
Microba secures $14.5 million to drive clinical adoption
|
23 Jun 2025 12:35PM |
$0.115 |
$0.072 |
fallen by
37.39%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Microba secures $14.5 million through an institutional placement.
- Funds will accelerate clinical adoption of the Microbiome Analysis Platform (MAP).
- Placement price set at $0.14 per share.
- Strong support from both existing and new institutional investors.
- Proceeds to be used for commercial infrastructure, clinical evidence generation, and expansion.
- Focus on international distribution and commercial partnerships.
- MAP is Microba’s flagship technology for microbiome analysis.
- The announcement highlights the company’s efforts to drive growth and global adoption in the microbiome sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$37 |
Notification of cessation of securities - MEC
|
23 Jun 2025 12:31PM |
$1.060 |
$1.210 |
risen by
14.15%
|
|
| Perpetual Credit Income Trust (PCI) ORDINARY UNITS FULLY PAID |
Financials |
$800 |
Daily Net Tangible Asset Statement
|
23 Jun 2025 12:19PM |
$1.180 |
$1.095 |
fallen by
7.20%
|
|
| Vital Metals Limited (VML) ORDINARY FULLY PAID |
Materials |
$37 |
Proposed issue of securities - VML
|
23 Jun 2025 12:18PM |
$0.002 |
$0.148 |
risen by
7,275%
|
|
| Abacus Group (ABG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$925 |
Dividend/Distribution - ABG
|
23 Jun 2025 12:14PM |
$1.178 |
$1.035 |
fallen by
12.10%
|
|
| Ronin Resources Ltd (RON) ORDINARY FULLY PAID |
Materials |
$7 |
Response to ASX Query Letter
|
23 Jun 2025 12:10PM |
$0.165 |
$0.165 |
fallen by
0%
|
|
RON - Price-sensitive ASX Announcement
Full Release
Key Points
- Ronin Resources Ltd responded to an ASX query regarding share price and trading volume changes.
- The company confirmed it is not aware of any undisclosed information that could explain recent trading activity.
- Ronin stated that there are no ongoing negotiations or events that have not been disclosed to the market.
- The company affirmed its compliance with ASX Listing Rule 3.1, ensuring continuous disclosure of material information.
- Directors and relevant company officers provided confirmations supporting the contents of the response.
- The correspondence demonstrates Ronin Resources Ltd’s commitment to transparency and regulatory compliance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tribeca Global Natural Resources Limited (TGF) ORDINARY FULLY PAID |
Financials |
$200 |
Estimated Weekly NTA as of 20 June 2025
|
23 Jun 2025 12:03PM |
$1.395 |
$2.720 |
risen by
94.98%
|
|
| Aldoro Resources Ltd (ARN) ORDINARY FULLY PAID |
Materials |
$100 |
Initial Director's Interest Notice
|
23 Jun 2025 12:03PM |
$0.320 |
$0.440 |
risen by
37.50%
|
|
| Orbminco Limited (OB1) ORDINARY FULLY PAID |
Materials |
$9 |
Extended Drilling Program at Majestic North Gold Project
|
23 Jun 2025 12:01PM |
$0.001 |
$0.015 |
risen by
1,350%
|
|
OB1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Orbminco Limited has started an extended RC drilling program at Majestic North Gold Project.
- The project is located in the Eastern Goldfields of Western Australia.
- Drilling targets high-priority gold zones identified by geophysical and geochemical surveys.
- The program follows positive results from prior exploration phases.
- Multiple drill holes are planned across different priority areas within the project.
- Recent technical reviews and updates underpin the expansion of drilling activities.
- The strategy aims to delineate and expand gold mineralization zones.
- OB1 plans to provide regular updates to the market as drilling results are received.
- This program is a key part of Orbminco's broader resource development plans at Majestic North.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Greenwing Resources Ltd (GW1) ORDINARY FULLY PAID |
Materials |
$38 |
Change of Director's Interest Notice
|
23 Jun 2025 12:00PM |
$0.024 |
$0.083 |
risen by
245.83%
|
|
| Greenwing Resources Ltd (GW1) ORDINARY FULLY PAID |
Materials |
$38 |
Change of Director's Interest Notice
|
23 Jun 2025 12:00PM |
$0.024 |
$0.083 |
risen by
245.83%
|
|
| Greenwing Resources Ltd (GW1) ORDINARY FULLY PAID |
Materials |
$38 |
Cleansing Statement
|
23 Jun 2025 11:59AM |
$0.024 |
$0.083 |
risen by
245.83%
|
|
Call 1300 880 160
Start a chat
Schedule a call
